Literature DB >> 647329

Plasma arginine vasopressin concentrations and antidiuretic action of carbamazepine.

W P Stephens, J Y Coe, P H Baylis.   

Abstract

Twelve subjects given therapeutic doses of carbamazepine showed no change in their plasma electrolyte concentrations. Ten of the 12 had abnormal water metabolism, however, their ability to excrete water loads being decreased. Plasma arginine vasopressin (AVP) concentrations fell while the subjects were taking the drug, indicating that the mechanism is unlikely to be increased secretion of antidiuretic hormone. We suggest that the water-retaining property of carbamazepine is a physiological effect of the drug, mediated by increased renal sensitivity to normal plasma concentrations of AVP and resetting of osmoreceptors.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 647329      PMCID: PMC1604924          DOI: 10.1136/bmj.1.6125.1445

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  2 in total

1.  The development of a radioimmunoassay for the measurement of human plasma arginine vasopressin.

Authors:  P H Baylis; D A Heath
Journal:  Clin Endocrinol (Oxf)       Date:  1977-08       Impact factor: 3.478

2.  The antidiuretic action of carbamazepine in man.

Authors:  A E Meinders; V Cejka; G L Robertson
Journal:  Clin Sci Mol Med       Date:  1974-10
  2 in total
  18 in total

1.  Mechanisms of carbamazepine-induced antidiuresis.

Authors:  W P Tormey
Journal:  J Neurol Neurosurg Psychiatry       Date:  1993-05       Impact factor: 10.154

2.  Plasma arginine vasopressin concentrations in epileptics under monotherapy.

Authors:  K H Krause; W Rascher; P Berlit
Journal:  J Neurol       Date:  1983       Impact factor: 4.849

3.  Water intoxication in epileptic patients receiving carbamazepine.

Authors:  E Perucca; A Garratt; S Hebdige; A Richens
Journal:  J Neurol Neurosurg Psychiatry       Date:  1978-08       Impact factor: 10.154

4.  Effects of long-term carbamazepine treatment on water metabolism and plasma vasopressin concentration.

Authors:  P Soelberg Sørensen; M Hammer
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

5.  Reversal by phenytoin of carbamazepine-induced water intoxication: a pharmacokinetic interaction.

Authors:  E Perucca; A Richens
Journal:  J Neurol Neurosurg Psychiatry       Date:  1980-06       Impact factor: 10.154

6.  Partial reversal of carbamazepine-induced water intolerance by demeclocycline.

Authors:  F W Ballardie; J C Mucklow
Journal:  Br J Clin Pharmacol       Date:  1984-06       Impact factor: 4.335

7.  Interferon-alpha is a predisposing risk factor for carbamazepine-induced hyponatremia: A case of syndrome of inappropriate antidiuresis caused by interferon-alpha therapy.

Authors:  Midori Tanaka; Kyuzi Kamoi; Toru Takahashi
Journal:  Int J Gen Med       Date:  2008-11-30

8.  Long-term treatment of trigeminal neuralgia with carbamazepine.

Authors:  J C Taylor; S Brauer; M L Espir
Journal:  Postgrad Med J       Date:  1981-01       Impact factor: 2.401

9.  Transepithelial water movement in response to carbamazepine, chlorpropamide and demeclocycline in toad urinary bladder.

Authors:  M R Hirji; J C Mucklow
Journal:  Br J Pharmacol       Date:  1991-10       Impact factor: 8.739

10.  The clinical challenge of SIADH-three cases.

Authors:  Nils van der Lubbe; Christopher J Thompson; Robert Zietse; Ewout J Hoorn
Journal:  NDT Plus       Date:  2009-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.